🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Gemcitabine platinum combined with erlotinib

Found 17 matching trials

Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

This ALCHEMIST trial studies genetic testing in screening patients with sta...

Status

Active Not Recruiting

Location

University of Alabama at Birmingham Cancer Center

Start Date

2014-09-26

Trial ID

NCT02194738

Treatments Being Tested

Biospecimen Collection Carboplatin Cisplatin Clinical Observation Computed Tomography Crizotinib Cytology Specimen Collection Procedure Echocardiography Test Erlotinib Gemcitabine Hydrochloride Nivolumab Paclitaxel Pembrolizumab Pemetrexed Pemetrexed Disodium Placebo Administration Positron Emission Tomography

A Study of Bevacizumab in Combination With First- or Second-Line Therapy in Subjects With Treated Brain Metastases Due to Non-Squamous NSCLC (PASSPORT)

PHASE2

This was an open-label, multicenter, single-arm, Phase II trial of bevacizu...

Status

Completed

Location

Multiple Locations

Start Date

2006-03

Trial ID

NCT00312728

Treatments Being Tested

bevacizumab First-Line Chemotherapy Agents Second-Line Chemotherapy Agents

Study of CGC-11047 When Used in Individual Combinations With 1) Gemcitabine or 2) Docetaxel or 3) Bevacizumab or 4) Erlotinib or 5) Cisplatin or 6) 5-Flurouracil or 7) Sunitinib in Patients With Advanced Solid Tumors or Lymphoma

PHASE1

This study will aims to determine the maximum tolerated dose of CGC-11047 w...

Status

Completed

Location

Rocky Mountain Cancer Centre

Start Date

2006-05

Trial ID

NCT00705874

Treatments Being Tested

CGC-11047 and gemcitabine CGC-11047 and docetaxel CGC-11047 and bevacizumab CGC-11047 and erlotinib CGC-11047 and cisplatin CGC-11047 and 5-flurouracil / leucovorin CGC-11047 and sunitinib

A Global Study to Assess the Effects of MEDI4736 (Durvalumab), Given as Monotherapy or in Combination With Tremelimumab Determined by PD-L1 Expression Versus Standard of Care in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer

PHASE3

This study is a Phase III, randomised, open label, multi-centre study asses...

Status

Completed

Location

Research Site

Start Date

2015-01-13

Trial ID

NCT02352948

Treatments Being Tested

MEDI4736 (durvalumab)Vinorelbine Gemcitabine Erlotinib MEDI4736 (durvalumab) in combination with tremelimumab (anti-CTLA4)tremelimumab (anti-CTLA4)

Erlotinib and Standard Platinum-Based Chemotherapy for Newly Diagnosed, Advanced Non-Small Cell Carcinoma of the Lung

PHASE2

This study was conducted to compare the activities of erlotinib to that of ...

Status

Terminated

Location

Lovelace Medical Group

Start Date

2006-07

Trial ID

NCT00391586

Treatments Being Tested

Erlotinib Platinum-based chemotherapy

Erlotinib Combined With Chemotherapy in TKI Resistant Non-Small Cell Lung Cancers

PHASE2

Numerous evidences verified that erlotinib could dramatically improve the P...

Status

Unknown

Location

Hunan Province Tumor Hospital

Start Date

2014-07-01

Trial ID

NCT02098954

Treatments Being Tested

Gemcitabine platinum combined with erlotinib

A Phase II Randomized Study Comparing the Efficacy and Safety of Targeted Therapy or Cancer Immunotherapy Versus Platinum-Based Chemotherapy in Patients With Cancer of Unknown Primary Site

PHASE2

This study will compare the efficacy and safety of molecularly-guided thera...

Status

Completed

Location

Blacktown Hospital

Start Date

2018-07-10

Trial ID

NCT03498521

Treatments Being Tested

Alectinib Vismodegib Ipatasertib Olaparib Erlotinib Bevacizumab Vemurafenib Cobimetinib Trastuzumab Subcutaneous (SC)Pertuzumab Atezolizumab Carboplatin Paclitaxel Cisplatin Gemcitabine Entrectinib Ivosidenib Pemigatinib

A Study of Tarceva (Erlotinib) in Combination With Platinum Based Chemotherapy in Patients With Non-Small Cell Lung Cancer.

PHASE2

This study will evaluate the efficacy and safety of sequential administrati...

Status

Completed

Location

Multiple Locations

Start Date

2006-08

Trial ID

NCT01998919

Treatments Being Tested

erlotinib [Tarceva]placebo gemcitabine cisplatin carboplatin

A Study of Tarceva (Erlotinib) or Placebo in Combination With Platinum-Based Therapy as First Line Treatment in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

PHASE3

This 2 arm study will compare the efficacy and safety of sequential treatme...

Status

Completed

Location

Multiple Locations

Start Date

2009-04

Trial ID

NCT00883779

Treatments Being Tested

Placebo Platinum chemotherapy (cisplatin or carboplatin)erlotinib [Tarceva]gemcitabine

Study of Nivolumab (BMS-936558) in Combination With Gemcitabine/Cisplatin, Pemetrexed/Cisplatin, Carboplatin/Paclitaxel, Bevacizumab Maintenance, Erlotinib, Ipilimumab or as Monotherapy in Subjects With Stage IIIB/IV Non-small Cell Lung Cancer (NSCLC) (CheckMate 012)

PHASE1

* The study is evaluating the safety and tolerability of Nivolumab (BMS-936...

Status

Completed

Location

Ucla

Start Date

2011-12-16

Trial ID

NCT01454102

Treatments Being Tested

Nivolumab Gemcitabine Cisplatin Pemetrexed Paclitaxel Carboplatin Bevacizumab Erlotinib Ipilimumab

Previous Next